Immune activation markers AIDS prognosis assays serum levels cellular products immune activation prognostic markers AIDS prospective study asymptomatic HIV-seropositive homosexual men Baseline serum values beta soluble soluble receptor men predictors AIDS months follow-up Thirty-three cases AIDS follow-up period assays good univariate predictors AIDS comparable lymphocyte count beta neopterin AIDS count HIV antigen antibody multivariate analysis range count cells/l immune activation marker combination assay antigen identifies risk AIDS months low risk assays risk high risk assays results physicians patients decisions asymptomatic HIV infection zidovudine individuals lymphocyte count cells/l 